The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children

Jeffrey Hyams, James Markowitz, Trudy Lerer, Anne Griffiths, David Mack, Athos Bousvaros, Anthony Otley, Jonathan Evans, Marian Pfefferkorn, Joel Rosh, Robert Rothbaum, Subra Kugathasan, Adam Mezoff, Robert Wyllie, Vasundhara Tolia, J. Fernando delRosario, M. Susan Moyer, Maria Oliva-Hemker, Neal LeLeiko

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

Background & Aims: The aim of this study was to determine the clinical outcome after corticosteroid therapy in children who are newly diagnosed with ulcerative colitis (UC). Methods: Data were gathered prospectively from the Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry database between January 2002 and March 2005. All children who were newly diagnosed with inflammatory bowel disease younger than the age of 16 years were managed according to the dictates of their respective physicians. Demographic, clinical, and laboratory data were collected at diagnosis, at 30 days, and then quarterly. Patients were classified as corticosteroid responsive, corticosteroid dependent, or refractory, and outcomes were determined at 3 months and at 1 year. Results: Ninety-seven patients had a diagnosis of UC and a minimum of 1 year of follow-up evaluation; 77 (79%) received corticosteroids (62 within 30 days of diagnosis [early] and 15 between 31 days and 6 months [late]). At diagnosis, 81% of corticosteroid-treated patients (age, 11.3 ± 3.5 y) had moderate/severe disease, and 81% had pancolitis. For those treated early with corticosteroids, disease activity at 3 months was inactive in 60%, mild in 27%, and moderate/severe in 11%. At 1 year, 31 of 62 (50%) of the early corticosteroid-treated patients were considered corticosteroid responsive and 28 (45%) were corticosteroid dependent. A total of 4 patients receiving corticosteroids (5%) required colectomy in the first year. Immunomodulators were used in 61% of all corticosteroid-treated patients. Conclusions: Although short-term clinical response to corticosteroids in children with newly diagnosed UC is excellent, even with the common use of immunomodulators corticosteroid dependence is seen in 45% of patients.

Original languageEnglish
Pages (from-to)1118-1123
Number of pages6
JournalClinical Gastroenterology and Hepatology
Volume4
Issue number9
DOIs
StatePublished - Sep 2006

Fingerprint

Natural History
Ulcerative Colitis
Adrenal Cortex Hormones
Therapeutics
Immunologic Factors
Inflammatory Bowel Diseases
Colectomy
Registries
Demography
Databases
Pediatrics
Physicians

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hyams, J., Markowitz, J., Lerer, T., Griffiths, A., Mack, D., Bousvaros, A., ... LeLeiko, N. (2006). The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children. Clinical Gastroenterology and Hepatology, 4(9), 1118-1123. https://doi.org/10.1016/j.cgh.2006.04.008

The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children. / Hyams, Jeffrey; Markowitz, James; Lerer, Trudy; Griffiths, Anne; Mack, David; Bousvaros, Athos; Otley, Anthony; Evans, Jonathan; Pfefferkorn, Marian; Rosh, Joel; Rothbaum, Robert; Kugathasan, Subra; Mezoff, Adam; Wyllie, Robert; Tolia, Vasundhara; delRosario, J. Fernando; Moyer, M. Susan; Oliva-Hemker, Maria; LeLeiko, Neal.

In: Clinical Gastroenterology and Hepatology, Vol. 4, No. 9, 09.2006, p. 1118-1123.

Research output: Contribution to journalArticle

Hyams, J, Markowitz, J, Lerer, T, Griffiths, A, Mack, D, Bousvaros, A, Otley, A, Evans, J, Pfefferkorn, M, Rosh, J, Rothbaum, R, Kugathasan, S, Mezoff, A, Wyllie, R, Tolia, V, delRosario, JF, Moyer, MS, Oliva-Hemker, M & LeLeiko, N 2006, 'The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children', Clinical Gastroenterology and Hepatology, vol. 4, no. 9, pp. 1118-1123. https://doi.org/10.1016/j.cgh.2006.04.008
Hyams, Jeffrey ; Markowitz, James ; Lerer, Trudy ; Griffiths, Anne ; Mack, David ; Bousvaros, Athos ; Otley, Anthony ; Evans, Jonathan ; Pfefferkorn, Marian ; Rosh, Joel ; Rothbaum, Robert ; Kugathasan, Subra ; Mezoff, Adam ; Wyllie, Robert ; Tolia, Vasundhara ; delRosario, J. Fernando ; Moyer, M. Susan ; Oliva-Hemker, Maria ; LeLeiko, Neal. / The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children. In: Clinical Gastroenterology and Hepatology. 2006 ; Vol. 4, No. 9. pp. 1118-1123.
@article{71401ab17e424964a73bdd12fd07051f,
title = "The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children",
abstract = "Background & Aims: The aim of this study was to determine the clinical outcome after corticosteroid therapy in children who are newly diagnosed with ulcerative colitis (UC). Methods: Data were gathered prospectively from the Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry database between January 2002 and March 2005. All children who were newly diagnosed with inflammatory bowel disease younger than the age of 16 years were managed according to the dictates of their respective physicians. Demographic, clinical, and laboratory data were collected at diagnosis, at 30 days, and then quarterly. Patients were classified as corticosteroid responsive, corticosteroid dependent, or refractory, and outcomes were determined at 3 months and at 1 year. Results: Ninety-seven patients had a diagnosis of UC and a minimum of 1 year of follow-up evaluation; 77 (79{\%}) received corticosteroids (62 within 30 days of diagnosis [early] and 15 between 31 days and 6 months [late]). At diagnosis, 81{\%} of corticosteroid-treated patients (age, 11.3 ± 3.5 y) had moderate/severe disease, and 81{\%} had pancolitis. For those treated early with corticosteroids, disease activity at 3 months was inactive in 60{\%}, mild in 27{\%}, and moderate/severe in 11{\%}. At 1 year, 31 of 62 (50{\%}) of the early corticosteroid-treated patients were considered corticosteroid responsive and 28 (45{\%}) were corticosteroid dependent. A total of 4 patients receiving corticosteroids (5{\%}) required colectomy in the first year. Immunomodulators were used in 61{\%} of all corticosteroid-treated patients. Conclusions: Although short-term clinical response to corticosteroids in children with newly diagnosed UC is excellent, even with the common use of immunomodulators corticosteroid dependence is seen in 45{\%} of patients.",
author = "Jeffrey Hyams and James Markowitz and Trudy Lerer and Anne Griffiths and David Mack and Athos Bousvaros and Anthony Otley and Jonathan Evans and Marian Pfefferkorn and Joel Rosh and Robert Rothbaum and Subra Kugathasan and Adam Mezoff and Robert Wyllie and Vasundhara Tolia and delRosario, {J. Fernando} and Moyer, {M. Susan} and Maria Oliva-Hemker and Neal LeLeiko",
year = "2006",
month = "9",
doi = "10.1016/j.cgh.2006.04.008",
language = "English",
volume = "4",
pages = "1118--1123",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - The Natural History of Corticosteroid Therapy for Ulcerative Colitis in Children

AU - Hyams, Jeffrey

AU - Markowitz, James

AU - Lerer, Trudy

AU - Griffiths, Anne

AU - Mack, David

AU - Bousvaros, Athos

AU - Otley, Anthony

AU - Evans, Jonathan

AU - Pfefferkorn, Marian

AU - Rosh, Joel

AU - Rothbaum, Robert

AU - Kugathasan, Subra

AU - Mezoff, Adam

AU - Wyllie, Robert

AU - Tolia, Vasundhara

AU - delRosario, J. Fernando

AU - Moyer, M. Susan

AU - Oliva-Hemker, Maria

AU - LeLeiko, Neal

PY - 2006/9

Y1 - 2006/9

N2 - Background & Aims: The aim of this study was to determine the clinical outcome after corticosteroid therapy in children who are newly diagnosed with ulcerative colitis (UC). Methods: Data were gathered prospectively from the Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry database between January 2002 and March 2005. All children who were newly diagnosed with inflammatory bowel disease younger than the age of 16 years were managed according to the dictates of their respective physicians. Demographic, clinical, and laboratory data were collected at diagnosis, at 30 days, and then quarterly. Patients were classified as corticosteroid responsive, corticosteroid dependent, or refractory, and outcomes were determined at 3 months and at 1 year. Results: Ninety-seven patients had a diagnosis of UC and a minimum of 1 year of follow-up evaluation; 77 (79%) received corticosteroids (62 within 30 days of diagnosis [early] and 15 between 31 days and 6 months [late]). At diagnosis, 81% of corticosteroid-treated patients (age, 11.3 ± 3.5 y) had moderate/severe disease, and 81% had pancolitis. For those treated early with corticosteroids, disease activity at 3 months was inactive in 60%, mild in 27%, and moderate/severe in 11%. At 1 year, 31 of 62 (50%) of the early corticosteroid-treated patients were considered corticosteroid responsive and 28 (45%) were corticosteroid dependent. A total of 4 patients receiving corticosteroids (5%) required colectomy in the first year. Immunomodulators were used in 61% of all corticosteroid-treated patients. Conclusions: Although short-term clinical response to corticosteroids in children with newly diagnosed UC is excellent, even with the common use of immunomodulators corticosteroid dependence is seen in 45% of patients.

AB - Background & Aims: The aim of this study was to determine the clinical outcome after corticosteroid therapy in children who are newly diagnosed with ulcerative colitis (UC). Methods: Data were gathered prospectively from the Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry database between January 2002 and March 2005. All children who were newly diagnosed with inflammatory bowel disease younger than the age of 16 years were managed according to the dictates of their respective physicians. Demographic, clinical, and laboratory data were collected at diagnosis, at 30 days, and then quarterly. Patients were classified as corticosteroid responsive, corticosteroid dependent, or refractory, and outcomes were determined at 3 months and at 1 year. Results: Ninety-seven patients had a diagnosis of UC and a minimum of 1 year of follow-up evaluation; 77 (79%) received corticosteroids (62 within 30 days of diagnosis [early] and 15 between 31 days and 6 months [late]). At diagnosis, 81% of corticosteroid-treated patients (age, 11.3 ± 3.5 y) had moderate/severe disease, and 81% had pancolitis. For those treated early with corticosteroids, disease activity at 3 months was inactive in 60%, mild in 27%, and moderate/severe in 11%. At 1 year, 31 of 62 (50%) of the early corticosteroid-treated patients were considered corticosteroid responsive and 28 (45%) were corticosteroid dependent. A total of 4 patients receiving corticosteroids (5%) required colectomy in the first year. Immunomodulators were used in 61% of all corticosteroid-treated patients. Conclusions: Although short-term clinical response to corticosteroids in children with newly diagnosed UC is excellent, even with the common use of immunomodulators corticosteroid dependence is seen in 45% of patients.

UR - http://www.scopus.com/inward/record.url?scp=33748210698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748210698&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2006.04.008

DO - 10.1016/j.cgh.2006.04.008

M3 - Article

VL - 4

SP - 1118

EP - 1123

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 9

ER -